Develops biologics for degenerative diseases and regenerative medicine.
Apr 2026Revenue $6.99M/yrExpenses $11.1M/yr
No trend
Figures by year
When will Zeo ScientifiX be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Apr 2026, revenue was $6.99M and expenses $11.1M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Oct 2025 | $5.20M | $10.6M | −$5.39M |
| Oct 2024 | $4.62M | $9.94M | −$5.32M |
| Oct 2023 | $4.56M | $11.3M | −$6.77M |
| Oct 2022 | $6.49M | $15.3M | −$8.84M |
| Oct 2021 | $5.60M | $18.3M | −$12.7M |
| Oct 2020 | $3.06M | $15.5M | −$12.4M |
| Oct 2019 | $1.70M | $3.48M | −$1.78M |
| Oct 2018 | $965K | $4.45M | −$3.49M |
| Oct 2017 | $570K | $9.21M | −$8.64M |
| Oct 2016 | $185K | $1.23M | −$1.04M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.